Patents Assigned to AnorMED
  • Patent number: 6417182
    Abstract: New pharmaceutical compositions and pharmaceutical compositions comprising metal complexes have activity against diseases caused by or related to overproduction or localized high concentration of nitric oxide in the body.
    Type: Grant
    Filed: March 9, 2001
    Date of Patent: July 9, 2002
    Assignee: AnorMED Inc.
    Inventors: Michael J Abrams, Simon P Fricker, Barry A Murrer, Owen J Vaughan
  • Patent number: 6413953
    Abstract: An improved platinum(IV) compound and its application as an antitumor agent are disclosed.
    Type: Grant
    Filed: October 4, 2000
    Date of Patent: July 2, 2002
    Assignee: AnorMED Inc.
    Inventors: Christen M. Gianomenico, Ernest S. Y. Wong
  • Patent number: 6365583
    Abstract: Methods to elevate white blood cell counts in animal subjects using compounds of formula (1) are disclosed.
    Type: Grant
    Filed: February 1, 2000
    Date of Patent: April 2, 2002
    Assignee: AnorMED, Inc.
    Inventors: Ronald Trevor MacFarland, Andrew W. Millar, Gary Bridger, Michael J. Abrams, Geoffrey W. Henson
  • Patent number: 6284752
    Abstract: New pharmaceutical compositions and pharmaceutical compositions comprising metal complexes have activity against diseases caused by or related to overproduction or localised high concentration of nitric oxide in the body.
    Type: Grant
    Filed: October 19, 1998
    Date of Patent: September 4, 2001
    Assignee: AnorMED Inc.
    Inventors: Michael J Abrams, Simon P Fricker, Barry A Murrer, Owen J Vaughan
  • Patent number: 6051596
    Abstract: A pharmaceutical composition containing a non-specific (NS) suppressor cell inducing compound and cyclosporin A and a pharmaceutically acceptable carrier or diluent, and method of inducing an immunosuppressive effect in a mammal, including a hyman, in need thereof which comprises administering an effective dose of a non-specific suppressor cell inducing compound and cyclosporin A to such mammal.
    Type: Grant
    Filed: August 1, 1997
    Date of Patent: April 18, 2000
    Assignee: AnorMED, Inc.
    Inventor: Alison Mary Badger
  • Patent number: 5981538
    Abstract: Invented is a method of treatment of psoriasis in a mammal in need thereof which comprises administering to such mammal an effective amount of a substituted azaspirane.
    Type: Grant
    Filed: January 29, 1997
    Date of Patent: November 9, 1999
    Assignee: AnorMED Inc.
    Inventors: Alison Mary Badger, Don Edgar Griswold
  • Patent number: 5952365
    Abstract: The present invention is directed to an improved antihyperlipidemic agent, the dimaleate salt of 2-?2-(dimethylamino)ethyl!-8,8-dipropyl-2-azaspiro?4.5!decane.
    Type: Grant
    Filed: January 12, 1998
    Date of Patent: September 14, 1999
    Assignee: AnorMED Inc.
    Inventors: Raymond E Dagger, Carolyn W Grady
  • Patent number: 5939450
    Abstract: An improved immunomodulatory agent, the dimaleate salt of N,N-dimethyl-8,8-dipropyl-2-azaspiro?4.5!decane-2-propanamine.
    Type: Grant
    Filed: January 12, 1998
    Date of Patent: August 17, 1999
    Assignee: AnorMED Inc.
    Inventors: Raymond E Dagger, Carolyn W Grady
  • Patent number: 5900430
    Abstract: Invented are methods of inhibiting the production of cytokines, particularly inhibiting the production of interleukin-1 and inhibiting the production of tumor necrosis factor in a mammal in need thereof which comprises administering to such mammal an effective amount of an azaspirane derivative.
    Type: Grant
    Filed: January 7, 1997
    Date of Patent: May 4, 1999
    Assignee: AnorMED, Inc.
    Inventors: Alison Mary Badger, Wanda Bernadette High